Olpasiran leads to significant and sustained reduction in oxidized phospholipids on apolipoprotein B. HealthDay News — Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback